期刊
JOURNAL OF LEUKOCYTE BIOLOGY
卷 86, 期 5, 页码 1089-1095出版社
WILEY
DOI: 10.1189/jlb.0209115
关键词
apoptosis; phagocytosis; macrophage; necrosis; Mertk; milk fat globule-epidermal growth factor 8 (MFG-E8 . lactadherin); transglutaminase 2; complement C1q; Fas; lysophosphatidylcholine
资金
- American Heart Association
- National Institutes of Health [HL54591, HL75662]
Throughout atherosclerotic lesion development, intimal macrophages undergo apoptosis, a form of death that usually prevents cellular necrosis. In advanced atherosclerotic lesions, however, these apoptotic macrophages become secondarily necrotic and coalesce over time into a key feature of vulnerable plaques, the necrotic core. This event is critically important, as necrotic core formation in these advanced atheromata is thought to promote plaque disruption and ultimately, acute atherothrombotic vascular disease. Increasing evidence suggests that the mechanism behind post-apoptotic macrophage necrosis in advanced atherosclerosis is defective phagocytic clearance or efferocytosis of the apoptotic cells. Thus, understanding the cellular and molecular mechanisms of efferocytosis in atherosclerosis and why efferocytosis becomes defective in advanced lesions is an important goal. Molecular-genetic causation studies in mouse models of advanced atherosclerosis have provided evidence that several molecules known to be involved in efferocytosis, including TG2, MFG-E8, complement C1q, Mertk, lysoPC, and Fas, play important roles in the clearance of apoptotic cells in advanced plaques. These and future insights into the molecular mechanisms of defective efferocytosis in advanced atheromata may open the way for novel therapeutic strategies for atherothrombotic vascular disease, the leading cause of death in the industrialized world. J. Leukoc. Biol. 86: 1089-1095; 2009.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据